Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children

Journal of Immunological Methods

Volumn 358, Issue 1-2, 2010, Pages 46-55

  Blanchard Rohner, Geraldine ^a,b   Galli, Grazia ^c   Clutterbuck, Elizabeth A ^a   Pollard, Andrew J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

ELISpot; Limiting dilution assay; Memory B cell; MenC; MenCV

Indexed keywords

DIPHTHERIA TOXOID; MENINGOCOCCUS VACCINE;

ARTICLE; BLOOD GROUP TYPING; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOASSAY; INFANCY; INFANT; INTERMETHOD COMPARISON; LIMITING DILUTION ASSAY; MEMORY CELL; MENINGOCOCCOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 4 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

B-LYMPHOCYTE SUBSETS; CELL SEPARATION; DIPHTHERIA TOXOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INFANT; LYMPHOCYTE COUNT; MENINGOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; VACCINATION;

EID: 77953285569     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.03.014     Document Type: Article

References (42)

1. Ahmed R., Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996, 272:54.
2. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 2007, 357:1903.
3. Auckland C., Gray S., Borrow R., Andrews N., Goldblatt D., Ramsay M., Miller E. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J. Infect. Dis. 2006, 194:1745.
4. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H., Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9237.
5. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199.
6. Blanchard Rohner G., Snape M.D., Kelly D.F., John T., Morant A., Yu L.M., Borkowski A., Ceddia F., Borrow R., Siegrist C.A., Pollard A.J. The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J. Immunol. 2008, 180:2165.
7. Blink E.J., Light A., Kallies A., Nutt S.L., Hodgkin P.D., Tarlinton D.M. Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J. Exp. Med. 2005, 201:545.
8. Carlone G.M., Frasch C.E., Siber G.R., Quataert S., Gheesling L.L., Turner S.H., et al. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1992, 30(1):154-159.
9. Clutterbuck E.A., Salt P., Oh S., Marchant A., Beverley P., Pollard A.J. The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine. Immunology 2006, 119:328.
10. Crotty S., Ahmed R. Immunological memory in humans. Semin. Immunol. 2004, 16:197.
11. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 2003, 171:4969.
12. Dogan I., Bertocci B., Vilmont V., Delbos F., Megret J., Storck S., Reynaud C.A., Weill J.C. Multiple layers of B cell memory with different effector functions. Nat. Immunol. 2009, 10:1292.
13. Dorfman J.R., Bejon P., Ndungu F.M., Langhorne J., Kortok M.M., Lowe B.S., Mwangi T.W., Williams T.N., Marsh K. B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J. Infect. Dis. 2005, 191:1623.
14. Falkoff R.J., Zhu L.P., Fauci A.S. Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. J. Immunol. 1982, 129(1):97-102.
15. Galli G., Hancock K., Hoschler K., DeVos J., Praus M., Bardelli M., Malzone C., Castellino F., Gentile C., McNally T., Del Giudice G., Banzhoff A., Brauer V., Montomoli E., Zambon M., Katz J., Nicholson K., Stephenson I. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7962.
16. Gheesling L.L., Carlone G.M., Pais L.B., Holder P.F., Maslanka S.E., Plikaytis B.D., Achtman M., Densen P., Frasch C.E., Kayhty H., et al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1994, 32:1475.
17. Heilmann C. Function of pokeweed mitogen-stimulated human T cells following vaccination with pneumococcal polysaccharides. Acta Pathol. Microbiol. Immunol. Scand. [C] 1987, 95:207.
18. Hodgkin P.D., Lee J.H., Lyons A.B. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 1996, 184:277.
19. Kelly D.F., Snape M., Clutterbuck E.C., Green S., Snowden C., Diggle L., Yu L.M., Borkowski A., Moxon E.R., Pollard A.J. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen specific memory B cells. Blood 2006, 108(8):2642-2647.
20. Kelly D.F., Snape M.D., Perrett K.P., Clutterbuck E.A., Lewis S., Rohner G.B., Jones M., Yu L.M., Pollard A.J. Plasma and memory B-cell kinetics in infants following a primary schedule of CRM-conjugated serogroup C meningococcal polysaccharide vaccine. Immunology 2008, 127(1):134-143.
21. Lanzavecchia A. One out of five peripheral blood B lymphocytes is activated to high-rate Ig production by human alloreactive T cell clones. Eur. J. Immunol. 1983, 13:820.
22. Lefkovits I., Waldmann H. Limiting Dilution Analysis of Cells in the Immune System 1999, Oxford University Press.
23. Leyendeckers H., Odendahl M., Lohndorf A., Irsch J., Spangfort M., Miltenyi S., Hunzelmann N., Assenmacher M., Radbruch A., Schmitz J. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur. J. Immunol. 1999, 29:1406.
24. MacLennan J.M., Shackley F., Heath P.T., Deeks J.J., Flamank C., Herbert M., Griffiths H., Hatzmann E., Goilav C., Moxon E.R. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial. Jama 2000, 283:2795.
25. Manz R.A., Arce S., Cassese G., Hauser A.E., Hiepe F., Radbruch A. Humoral immunity and long-lived plasma cells. Curr. Opin. Immunol. 2002, 14:517.
26. Maruyama M., Lam K.P., Rajewsky K. Memory B-cell persistence is independent of persisting immunizing antigen. Nature 2000, 407:636.
27. Mingari M.C., Gerosa F., Carra G., Accolla R.S., Moretta A., Zubler R.H., Waldmann T.A., Moretta L. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 1984, 312:641.
28. Nanan R., Heinrich D., Frosch M., Kreth H.W. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine 2001, 20:498.
29. Nespoli L., Vitiello A., Maccario R., Lanzavecchia A., Ugazio A.G. Polyclonal activation of human B lymphocytes in vitro by pokeweed mitogen: a simple technique for the simultaneous assessment of cell proliferation, generation of plasma cells, plaque-forming cells and immunoglobulin production. Scand. J. Immunol. 1978, 8:489.
30. Odendahl M., Mei H., Hoyer B.F., Jacobi A.M., Hansen A., Muehlinghaus G., Berek C., Hiepe F., Manz R., Radbruch A., Dorner T. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005, 105:1614.
31. Osmond D.G. Population dynamics of bone marrow B lymphocytes. Immunol. Rev. 1986, 93:103.
32. Pollard A.J., Perrett K.P., Beverley P.C. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat. Rev. Immunol. 2009, 9:213.
33. Reed L.J., Muench H. A simple method of estimating fifty per cent endpont. Am. J. Hyg. 1938, 27:493.
34. Richmond P., Borrow R., Miller E., Clark S., Sadler F., Fox A., Begg N., Morris R., Cartwright K. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J. Infect. Dis. 1999, 179:1569.
35. Ruprecht C.R., Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur. J. Immunol. 2006, 36:810.
36. Siegrist C.A., Aspinall R. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 2009, 9:185.
37. Slifka M.K., Antia R., Whitmire J.K., Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998, 8:363.
38. Slifka M.K., Matloubian M., Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 1995, 69:1895.
39. Suzuki N., Ueda Y., Sakane T. Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density. J. Clin. Invest. 1988, 81(1):261-269.
40. Takeshita F., Leifer C.A., Gursel I., Ishii K.J., Takeshita S., Gursel M., Klinman D.M. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 2001, 167:3555.
41. Trotter C.L., Andrews N.J., Kaczmarski E.B., Miller E., Ramsay M.E. Effectiveness of meningococcal serogroup C conjugate vaccine 4years after introduction. Lancet 2004, 364:365.
42. Tvede N., Heilmann C., Christensen L.D. Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides. Clin. Exp. Immunol. 1989, 76:404.